Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01147601 · ClinicalTrials.gov registry record · Early Phase 1
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT01147601 is a Early Phase 1 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 6 participants.
The verdict
NCT01147601, a Early Phase 1 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas. This study would examine whether topical timolol could be a potential therapy.
Interventions
- DRUG topical 0.5% Timolol
- DRUG Control (placebo) group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01147601
The ClinicalTrials.gov registry entry for NCT01147601 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which topical 0.5% Timolol is the first listed.
NCT01147601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01147601 about?
NCT01147601 is a clinical study titled "Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas". The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas. This study would examine whether topical timolol could be a potential therapy.
What is the current status of trial NCT01147601?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2010-03. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01147601?
The interventions under investigation include: topical 0.5% Timolol (DRUG), Control (placebo) group (DRUG).
Who is sponsoring clinical trial NCT01147601?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.